Login to Your Account

Regulatory NEWS

HONG KONG – Looking to improve regulatory coordination and supervision of drug and food markets, the Chinese government may merge together several agencies – including the China FDA (CFDA) – into an umbrella State Drug Administration (SDA) with national scope.

Despite warnings of unintended consequences, the U.S. House could take another step this week toward making right-to-try legislation the law of the land.

As the November 2023 deadline for the full implementation of the Drug Supply Chain Security Act (DSCSA) approaches, the FDA continues to meet with stakeholders to work out some of the kinks.

More Regulatory Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: